Efficacy of infliximab after loss of response of/intolerance to adalimumab in pediatric Crohn’s disease
Publiée
A retrospective multicenter cohort study of the « GETAID pediatrique »
Lecoutour A, Dupont C, Caldari D, Dumant C, Vanrenterghem A, Ruiz M, Duclaux-Loras R, Berthet S, Dimitrov G, Lacroix D, Duvant P, Roman C, Wagner AC, Bourmaud A, Viala J, Ruemmele FM, Pigneur B; GETAID pédiatrique group.J Pediatr Gastroenterol Nutr. 2024 Jan 7. doi: 10.1002/jpn3.12044. Online ahead of print.PMID: 38314896